Literature DB >> 20978977

Optimized generation of high-affinity, high-specificity single-chain Fv antibodies from multiantigen immunized chickens.

William J J Finlay1, Laird Bloom, Orla Cunningham.   

Abstract

High-affinity, highly specific binding proteins are a key class of molecules used in the development of new affinity chromatography methods. Traditionally, antibody-based methods have relied on the use of whole immunoglobulins purified from immune animal sera, from egg yolks, or from murine monoclonal hybridoma supernatants. To accelerate and refine the reagent antibody generation process, we have developed optimized methods that allow the rapid assembly of scFv libraries from chickens immunized with pools of immunogens. These methods allow the simplified generation of a single moderately sized library of single-chain Fv (scFv) and the subsequent isolation of diverse, high-affinity, and high-specificity monoclonals for each individual immunogen, via phage display. Using these methods, antibodies can be derived that exhibit the desired selectivity, such as complete specificity or cross-reactivity to multiple orthologues of the same protein.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20978977     DOI: 10.1007/978-1-60761-913-0_21

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

Review 1.  Phage display--a powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications.

Authors:  Justyna Bazan; Ireneusz Całkosiński; Andrzej Gamian
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

2.  An ultra-specific avian antibody to phosphorylated tau protein reveals a unique mechanism for phosphoepitope recognition.

Authors:  Heather H Shih; Chao Tu; Wei Cao; Anne Klein; Renee Ramsey; Brian J Fennell; Matthew Lambert; Deirdre Ní Shúilleabháin; Bénédicte Autin; Eugenia Kouranova; Sri Laxmanan; Steven Braithwaite; Leeying Wu; Mostafa Ait-Zahra; Anthony J Milici; Jo Ann Dumin; Edward R LaVallie; Maya Arai; Christopher Corcoran; Janet E Paulsen; Davinder Gill; Orla Cunningham; Joel Bard; Lydia Mosyak; William J J Finlay
Journal:  J Biol Chem       Date:  2012-11-12       Impact factor: 5.157

3.  CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous delivery.

Authors:  Brian J Fennell; Barry McDonnell; Amy Sze Pui Tam; Lijun Chang; John Steven; Ian D Broadbent; Huilan Gao; Elizabeth Kieras; Jennifer Alley; Deborah Luxenberg; Jason Edmonds; Lori J Fitz; Wenyan Miao; Matthew J Whitters; Quintus G Medley; Yongjing J Guo; Alfredo Darmanin-Sheehan; Bénédicte Autin; Deirdre Ní Shúilleabháin; Emma Cummins; Amy King; Mark R H Krebs; Christopher Grace; Timothy P Hickling; Angela Boisvert; Xiaotian Zhong; Matthew McKenna; Christopher Francis; Stephane Olland; Laird Bloom; Janet Paulsen; Will Somers; Allan Jensen; Laura Lin; William J J Finlay; Orla Cunningham
Journal:  MAbs       Date:  2013-08-21       Impact factor: 5.857

4.  Anti-PD1 'SHR-1210' aberrantly targets pro-angiogenic receptors and this polyspecificity can be ablated by paratope refinement.

Authors:  William J J Finlay; James E Coleman; Jonathan S Edwards; Kevin S Johnson
Journal:  MAbs       Date:  2018-12-12       Impact factor: 5.857

5.  In vitro affinity optimization of an anti-BDNF monoclonal antibody translates to improved potency in targeting chronic pain states in vivo.

Authors:  Edwina Stack; Sheridan McMurray; Gordon McMurray; Jason Wade; Melissa Clark; Gareth Young; Kim Marquette; Sadhana Jain; Kerry Kelleher; Ting Chen; Qingcong Lin; Laird Bloom; Laura Lin; William Finlay; Rie Suzuki; Orla Cunningham
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

6.  Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumors.

Authors:  Adam R Root; Gurkan Guntas; Madan Katragadda; James R Apgar; Jatin Narula; Chew Shun Chang; Sara Hanscom; Matthew McKenna; Jason Wade; Caryl Meade; Weijun Ma; Yongjing Guo; Yan Liu; Weili Duan; Claire Hendershot; Amy C King; Yan Zhang; Eric Sousa; Amy Tam; Susan Benard; Han Yang; Kerry Kelleher; Fang Jin; Nicole Piche-Nicholas; Sinead E Keating; Fernando Narciandi; Rosemary Lawrence-Henderson; Maya Arai; Wayne R Stochaj; Kristine Svenson; Lidia Mosyak; Khetemcnee Lam; Christopher Francis; Kimberly Marquette; Liliana Wroblewska; H Lily Zhu; Alfredo Darmanin Sheehan; Edward R LaVallie; Aaron M D'Antona; Alison Betts; Lindsay King; Edward Rosfjord; Orla Cunningham; Laura Lin; Puja Sapra; Lioudmila Tchistiakova; Divya Mathur; Laird Bloom
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

7.  Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia.

Authors:  João Arezes; Niall Foy; Kirsty McHugh; Doris Quinkert; Susan Benard; Anagha Sawant; Joe N Frost; Andrew E Armitage; Sant-Rayn Pasricha; Pei Jin Lim; May S Tam; Edward Lavallie; Debra D Pittman; Orla Cunningham; Matthew Lambert; John E Murphy; Simon J Draper; Reema Jasuja; Hal Drakesmith
Journal:  Blood       Date:  2020-02-20       Impact factor: 25.476

8.  Systematic characterization and comparative analysis of the rabbit immunoglobulin repertoire.

Authors:  Jason J Lavinder; Kam Hon Hoi; Sai T Reddy; Yariv Wine; George Georgiou
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

9.  8(th) Annual European Antibody Congress 2012: November 27-28, 2012, Geneva, Switzerland.

Authors:  Alain Beck; Paul J Carter; Hans-Peter Gerber; Alexey A Lugovskoy; Thierry Wurch; Jagath R Junutula; Roland E Kontermann; Robert Mabry
Journal:  MAbs       Date:  2013-03-14       Impact factor: 5.857

10.  Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma.

Authors:  De-Xiu Bu; Reshma Singh; Eugene E Choi; Marco Ruella; Selene Nunez-Cruz; Keith G Mansfield; Paul Bennett; Nathanial Barton; Qilong Wu; Jiquan Zhang; Yongqiang Wang; Lai Wei; Shawn Cogan; Tucker Ezell; Shree Joshi; Kellie J Latimer; Brian Granda; William R Tschantz; Regina M Young; Heather A Huet; Celeste J Richardson; Michael C Milone
Journal:  Oncotarget       Date:  2018-05-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.